Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALACHITE INNOVATIONS, INC.

(MLCT)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Vitality Biopharma, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021

08/13/2021 | 04:06pm EDT

Vitality Biopharma, Inc. announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced operating loss was USD 612,249 compared to USD 740,717 a year ago. Net loss was USD 612,235 compared to USD 740,238 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.


© S&P Capital IQ 2021
All news about MALACHITE INNOVATIONS, INC.
10/12VITALITY BIOPHARMA : ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC - Form 8-K
PU
10/12VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Artic..
AQ
10/12VITALITY BIOPHARMA : Adopts New Name – Malachite Innovations, Inc.
GL
10/12Malachite Innovations, Inc. Announces Change of Corporate Headquarters
CI
10/12Malachite Innovations, Inc. Announces Fiscal Year Change
CI
10/12Malachite Innovations, Inc. has Changed its Ticker to MLCT from VBIO
CI
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY (F..
PU
09/02VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/23VITALITY BIOPHARMA : Enters into $5 million equity financing relationship with institution..
AQ
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 18,4 M 18,4 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,4%
Chart MALACHITE INNOVATIONS, INC.
Duration : Period :
Malachite Innovations, Inc. Technical Analysis Chart | MLCT | US56089M1071 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard F. Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MALACHITE INNOVATIONS, INC.500.00%18
GILEAD SCIENCES, INC.14.98%83 830
BIONTECH SE251.28%65 071
WUXI APPTEC CO., LTD.25.77%64 894
REGENERON PHARMACEUTICALS17.86%58 504
VERTEX PHARMACEUTICALS-20.84%48 121